PROEHL GERALD T
SEC insider (Form 3/4/5 filer). CIK 0001279191. PRESIDENT, CHAIRMAN, CEO at Dermata Therapeutics, Inc. (DRMA) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 16, 2026. Located in SAN DIEGO, CA.
Companies PROEHL GERALD T has filed insider reports for
- Dermata Therapeutics, Inc. (DRMA): Director, Officer, 10% Owner, PRESIDENT, CHAIRMAN, CEO
- TENAX THERAPEUTICS, INC. (TENX): Director
PROEHL GERALD T
CIK: 0001279191
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 16, 2026DRMA
Dermata Therapeutics, Inc.
AwardIndirect170.1K shares- - Jan 9, 2026TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
3K shares- - Jan 2, 2026DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (right to buy)
37.5K shares- - Dec 23, 2025DRMA
Dermata Therapeutics, Inc.
AwardIndirect490.2K shares- - Dec 23, 2025DRMA
Dermata Therapeutics, Inc.
AwardIndirect122.5K shares- - Dec 23, 2025DRMA
Dermata Therapeutics, Inc.
DispositionDirectWarrant (Right to Buy)
78.7K shares- - Jul 1, 2025TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
80K shares- - Jan 21, 2025DRMA
Dermata Therapeutics, Inc.
AwardIndirect787.4K shares- - Jan 13, 2025DRMA
Dermata Therapeutics, Inc.
AwardDirectStock Option (right to buy)
45K shares- - Dec 10, 2024TENX
TENAX THERAPEUTICS, INC.
AwardDirectStock Option (right to buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 16, 2026 |  DRMA Dermata Therapeutics, Inc. | Award | 170,068 | - | $0 | Indirect |
| Jan 9, 2026 |  TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 3,000 | - | - | Direct |
| Jan 2, 2026 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (right to buy) | 37,500 | - | - | Direct |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 490,196 | - | - | Indirect |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 122,549 | - | - | Indirect |
| Dec 23, 2025 | DRMA Dermata Therapeutics, Inc. | Disposition Warrant (Right to Buy) | 78,740 | - | - | Direct |
| Jul 1, 2025 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 80,000 | - | - | Direct |
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | Award | 787,402 | - | $0 | Indirect |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | Award Stock Option (right to buy) | 45,000 | - | - | Direct |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
1-10 of 10 transactions